57 related articles for article (PubMed ID: 34406653)
1. Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients.
Zhang C; Wang X; Han J; Zhang R; Chen Z; Li Y; Ma X; Zhang G; Fan J; Chen J
J Surg Oncol; 2021 Dec; 124(8):1431-1441. PubMed ID: 34406653
[TBL] [Abstract][Full Text] [Related]
2. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
Liang JY; Xi SY; Shao Q; Yuan YF; Li BK; Zheng Y; Wang DS; Wu XJ; Ding PR; Chen G; Li LR; Wang FH; Wang ZQ; Pan ZZ; Xu RH; Li YH
Cancer Immunol Immunother; 2020 Dec; 69(12):2623-2634. PubMed ID: 32601799
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
Laroche S; Scatton O; Charlotte F; Bachet JB; Lim C; Fuks D; Goumard C
Ann Surg Oncol; 2024 Jul; 31(7):4436-4444. PubMed ID: 38549003
[TBL] [Abstract][Full Text] [Related]
4. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
[TBL] [Abstract][Full Text] [Related]
5. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.
Liao L; Sun H; He J; Liu Y; Pan Z; Wu X; Fan W; Peng J; Li C
BMC Surg; 2023 Sep; 23(1):271. PubMed ID: 37689651
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma.
Henckens SPG; Liu D; Gisbertz SS; Kalff MC; Anderegg MCJ; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; van Duijvendijk P; Eshuis WJ; Groenendijk RPR; Haveman JW; van Hillegersberg R; Luyer MDP; Olthof PB; Pierie JEN; Plat VD; Rosman C; Ruurda JP; van Sandick JW; Sosef MN; Voeten DM; Vijgen GHEJ; Bijlsma MF; Meijer SL; Hulshof MCCM; Oyarce C; Lagarde SM; van Laarhoven HWM; van Berge Henegouwen MI;
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38387083
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
Scaglione G; Arciuolo D; Travaglino A; Santoro A; Angelico G; Spadola S; Inzani F; D'Alessandris N; Raffone A; Fulgione C; Padial Urtueta B; Sfregola S; Valente M; Addante F; d'Amati A; Cianfrini F; Piermattei A; Pedone Anchora L; Scambia G; Ferrandina G; Zannoni GF
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892049
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer.
El Sissy C; Kirilovsky A; Zeitoun G; Marliot F; Haicheur N; Lagorce-Pagès C; Galon J; Pagès F
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33805758
[TBL] [Abstract][Full Text] [Related]
10. ASO Visual Abstract: Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients Who Undergo Resection for Colorectal Liver Metastases.
Laroche S; Scatton O; Charlotte F; Bachet JB; Lim C; Fuks D; Goumard C
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38782823
[No Abstract] [Full Text] [Related]
11. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts.
Zhang C; Wang XY; Zhang P; He TC; Han JH; Zhang R; Lin J; Fan J; Lu L; Zhu WW; Jia HL; Zhang JB; Chen JH
Cell Death Dis; 2022 Jan; 13(1):57. PubMed ID: 35027547
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases.
Han J; Wang X; Zhang C; Wu Q; Ma X; Li Y; Chen Z; Zhang R; Zhang G; Lin J; Lu L; Zhu W; Jia H; Zhang J; Fan J; Chen J
J Surg Oncol; 2022 May; 125(6):991-1001. PubMed ID: 35150441
[TBL] [Abstract][Full Text] [Related]
14. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract][Full Text] [Related]
15. Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma.
Nie Y; Fan H; Li J; Lei X; Zhang T; Wang Y; Mao Z; Tao K; Song W
FASEB J; 2022 Nov; 36(11):e22586. PubMed ID: 36190431
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers.
Xu Y; Wei Z; Feng M; Zhu D; Mei S; Wu Z; Feng Q; Chang W; Ji M; Liu C; Zhu Y; Shen L; Yang F; Chen Y; Feng Y; Xu J; Zhu D
Cell Rep; 2022 Aug; 40(9):111295. PubMed ID: 36044847
[TBL] [Abstract][Full Text] [Related]
17. Immune phenotypic linkage between colorectal cancer and liver metastasis.
Liu Y; Zhang Q; Xing B; Luo N; Gao R; Yu K; Hu X; Bu Z; Peng J; Ren X; Zhang Z
Cancer Cell; 2022 Apr; 40(4):424-437.e5. PubMed ID: 35303421
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of tertiary lymphoid structures in breast cancer prognosis: a systematic review and meta-analysis.
Zhang NN; Qu FJ; Liu H; Li ZJ; Zhang YC; Han X; Zhu ZY; Lv Y
Cancer Cell Int; 2021 Oct; 21(1):536. PubMed ID: 34654433
[TBL] [Abstract][Full Text] [Related]
19. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.
Zhao H; Wang H; Zhou Q; Ren X
Cancer Biol Med; 2021 Sep; 18(4):981-91. PubMed ID: 34553849
[TBL] [Abstract][Full Text] [Related]
20. Minimally Invasive Compared to Open Colorectal Cancer Resection for Older Adults: A Population-based Analysis of Long-term Functional Outcomes.
Behman R; Chesney T; Coburn N; Haas B; Bubis L; Zuk V; Ashamalla S; Zhao H; Mahar A; Hallet J;
Ann Surg; 2023 Feb; 277(2):291-298. PubMed ID: 34417359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
